|
Volumn 57, Issue 2, 2011, Pages 146-147
|
Stiff endothelial cell syndrome in vascular inflammation and mineralocorticoid excess
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALDOSTERONE;
AMILORIDE;
ANGIOTENSIN II;
C REACTIVE PROTEIN;
CONNECTIVE TISSUE GROWTH FACTOR;
EPITHELIAL SODIUM CHANNEL;
I KAPPA B;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
MINERALOCORTICOID;
NITRIC OXIDE;
PHOSPHATIDYLINOSITOL 3 KINASE;
SERUM AND GLUCOCORTICOID REGULATED KINASE 1;
SODIUM;
SPIRONOLACTONE;
VON WILLEBRAND FACTOR;
ATOMIC FORCE MICROSCOPY;
CELL SWELLING;
DRUG EFFICACY;
ENDOTHELIAL DYSFUNCTION;
ENDOTHELIUM CELL;
HUMAN;
IMMUNOFLUORESCENCE;
KIDNEY FIBROSIS;
NEPHRON;
NOTE;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
STIFF ENDOTHELIAL CELL SYNDROME;
UPREGULATION;
VASCULITIS;
VASODILATATION;
ALDOSTERONE;
AMILORIDE;
ANIMALS;
AORTA;
C-REACTIVE PROTEIN;
CELL MEMBRANE PERMEABILITY;
CELLS, CULTURED;
CHROMONES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENDOTHELIAL CELLS;
ENZYME INHIBITORS;
EPITHELIAL SODIUM CHANNEL;
HUMANS;
MODELS, BIOLOGICAL;
MORPHOLINES;
PHOSPHATIDYLINOSITOL 3-KINASES;
SODIUM AZIDE;
VASODILATOR AGENTS;
|
EID: 79551469279
PISSN: 0194911X
EISSN: None
Source Type: Journal
DOI: 10.1161/HYPERTENSIONAHA.110.164558 Document Type: Note |
Times cited : (54)
|
References (10)
|